Echo Therapeutics Stock Price, News & Analysis (OTCMKTS:ECTE)

$0.01 0.00 (0.00 %)
(As of 12/15/2017 10:59 AM ET)
Previous Close$0.01
Today's Range$0.01 - $0.01
52-Week RangeN/A
Volume2,523 shs
Average Volume27,608 shs
Market Capitalization$120,000.00
P/E RatioN/A
Dividend YieldN/A
Beta1.81

About Echo Therapeutics (OTCMKTS:ECTE)

Echo Therapeutics logoEcho Therapeutics, Inc. is a medical device company. The Company is engaged in developing a non-invasive, wireless continuous glucose monitoring (CGM) system with use in the wearable-health consumer market, diabetes outpatient market and in the hospital setting. The Company operates through the development of transdermal skin permeation and diagnostic medical devices segment. The Company has also developed its needle-free skin preparation device as a platform technology that allows for enhanced skin permeation enabling extraction of analytes, such as glucose, enhanced delivery of topical pharmaceuticals and other applications. The CGM System includes a skin preparation device, transdermal glucose sensor, battery and wireless transmitter. The Company has conducted several human feasibility clinical studies with its CGM System in healthy subjects, diabetics and critically ill patients, as well as a clinical study at several hospitals in the United States.

Receive ECTE News and Ratings via Email

Sign-up to receive the latest news and ratings for ECTE and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Drug Manufacturers - Major
Sub-IndustryN/A
SectorMedical
SymbolOTCMKTS:ECTE
CUSIPN/A
Phone732-549-0128

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$60,000.00
Price / Sales2.02
Cash FlowN/A
Price / CashN/A
Book Value($0.23) per share
Price / Book-0.04

Profitability

Trailing EPSN/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

EmployeesN/A
Outstanding Shares12,000,000

Echo Therapeutics (OTCMKTS:ECTE) Frequently Asked Questions

What is Echo Therapeutics' stock symbol?

Echo Therapeutics trades on the OTCMKTS under the ticker symbol "ECTE."

How were Echo Therapeutics' earnings last quarter?

Echo Therapeutics Inc. (OTCMKTS:ECTE) issued its quarterly earnings results on Friday, August, 12th. The medical device company reported ($0.82) earnings per share for the quarter. During the same period last year, the firm posted ($0.97) EPS. View Echo Therapeutics' Earnings History.

When will Echo Therapeutics make its next earnings announcement?

Echo Therapeutics is scheduled to release their next quarterly earnings announcement on Wednesday, December, 20th 2017. View Earnings Estimates for Echo Therapeutics.

Who are some of Echo Therapeutics' key competitors?

Who are Echo Therapeutics' key executives?

Echo Therapeutics' management team includes the folowing people:

  • Alan W. Schoenbart CPA, Chief Executive Officer, Chief Financial Officer, Secretary, Director (Age 58)

How do I buy Echo Therapeutics stock?

Shares of Echo Therapeutics can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Echo Therapeutics' stock price today?

One share of Echo Therapeutics stock can currently be purchased for approximately $0.01.

How big of a company is Echo Therapeutics?

Echo Therapeutics has a market capitalization of $120,000.00 and generates $60,000.00 in revenue each year. The medical device company earns $-22,190,000.00 in net income (profit) each year or ($1.28) on an earnings per share basis.

How can I contact Echo Therapeutics?

Echo Therapeutics' mailing address is 99 WOOD AVENUE SOUTH SUITE 302, ISELIN NJ, 08830. The medical device company can be reached via phone at 732-549-0128 or via email at [email protected]


MarketBeat Community Rating for Echo Therapeutics (ECTE)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  70 (Vote Outperform)
Underperform Votes:  56 (Vote Underperform)
Total Votes:  126
MarketBeat's community ratings are surveys of what our community members think about Echo Therapeutics and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Echo Therapeutics (OTCMKTS:ECTE) Analyst Ratings History


No equities research coverage for this company has been tracked by MarketBeat

Earnings

Echo Therapeutics (OTCMKTS:ECTE) Earnings History and Estimates Chart

Earnings by Quarter for Echo Therapeutics (OTCMKTS:ECTE)

Echo Therapeutics (OTCMKTS ECTE) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
12/20/2017        
8/12/2016Q2($0.82)ViewN/AView Earnings Details
5/20/2016Q1($0.23)ViewN/AView Earnings Details
11/16/2015Q3 15($0.16)ViewN/AView Earnings Details
8/14/2015Q215($0.97)ViewN/AView Earnings Details
5/15/2015Q1 15($0.72)ViewN/AView Earnings Details
11/19/2014Q314($0.31)($0.43)$19.11 millionViewN/AView Earnings Details
8/14/2014Q214($0.23)($0.31)$22.56 million$19.10 millionViewN/AView Earnings Details
5/9/2014Q114($0.26)($0.23)$0.02 million$0.02 millionViewN/AView Earnings Details
3/27/2014Q413($0.36)($0.35)$0.02 million($0.04) millionViewN/AView Earnings Details
11/7/2013($0.56)($0.48)ViewN/AView Earnings Details
8/8/2013Q2 2013($0.81)($0.51)$10.00 million$22.56 millionViewN/AView Earnings Details
5/10/2013Q1 2013($0.10)($0.13)$0.01 millionViewN/AView Earnings Details
11/8/2012Q312($0.09)($0.11)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Echo Therapeutics (OTCMKTS:ECTE) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Echo Therapeutics (OTCMKTS:ECTE)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Echo Therapeutics (OTCMKTS ECTE) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 7.00%
Insider Trades by Quarter for Echo Therapeutics (OTCMKTS:ECTE)

Echo Therapeutics (OTCMKTS ECTE) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/20/2015Alan Wayne SchoenbartCFOBuy2,500$1.44$3,600.00View SEC Filing  
5/20/2015Scott Wayne HollanderCEOBuy8,000$1.48$11,840.00View SEC Filing  
6/30/2014Mark NordlichtMajor ShareholderBuy65,739$2.20$144,625.80View SEC Filing  
6/26/2014Mark NordlichtMajor ShareholderBuy17,300$2.20$38,060.00View SEC Filing  
6/24/2014Mark NordlichtMajor ShareholderBuy16,961$2.20$37,314.20View SEC Filing  
12/10/2013Mark Nordlichtmajor shareholderBuy69,569$2.75$191,314.75View SEC Filing  
3/22/2013Robert F DomanDirectorBuy15,000$0.80$12,000.00View SEC Filing  
3/21/2013William GriecoDirectorBuy30,000$0.76$22,800.00View SEC Filing  
8/23/2012James Francis SmithDirectorBuy20,000$1.47$29,400.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Echo Therapeutics (OTCMKTS ECTE) News Headlines

Source:
DateHeadline
Contrasting Innovus Pharmaceuticals (INNV) and Echo Therapeutics (ECTE)Contrasting Innovus Pharmaceuticals (INNV) and Echo Therapeutics (ECTE)
www.americanbankingnews.com - December 13 at 9:18 PM
Head to Head Review: Innovus Pharmaceuticals (INNV) versus Echo Therapeutics (ECTE)Head to Head Review: Innovus Pharmaceuticals (INNV) versus Echo Therapeutics (ECTE)
www.americanbankingnews.com - December 13 at 5:12 AM
Comparing Tonix Pharmaceuticals (TNXP) and Echo Therapeutics (ECTE)Comparing Tonix Pharmaceuticals (TNXP) and Echo Therapeutics (ECTE)
www.americanbankingnews.com - December 9 at 1:18 PM
Financial Comparison: Innovus Pharmaceuticals (INNV) & Echo Therapeutics (ECTE)Financial Comparison: Innovus Pharmaceuticals (INNV) & Echo Therapeutics (ECTE)
www.americanbankingnews.com - December 8 at 11:30 PM
Innovus Pharmaceuticals (INNV) & Echo Therapeutics (ECTE) Critical ReviewInnovus Pharmaceuticals (INNV) & Echo Therapeutics (ECTE) Critical Review
www.americanbankingnews.com - December 8 at 3:52 PM
Comparing Innovus Pharmaceuticals (INNV) and Echo Therapeutics (ECTE)Comparing Innovus Pharmaceuticals (INNV) and Echo Therapeutics (ECTE)
www.americanbankingnews.com - December 8 at 8:40 AM
Comparing Echo Therapeutics (ECTE) and Tonix Pharmaceuticals (TNXP)Comparing Echo Therapeutics (ECTE) and Tonix Pharmaceuticals (TNXP)
www.americanbankingnews.com - December 7 at 5:30 AM
Comparing Echo Therapeutics (ECTE) & Innovus Pharmaceuticals (INNV)Comparing Echo Therapeutics (ECTE) & Innovus Pharmaceuticals (INNV)
www.americanbankingnews.com - December 3 at 4:38 PM
Reviewing Innovus Pharmaceuticals (INNV) & Echo Therapeutics (ECTE)Reviewing Innovus Pharmaceuticals (INNV) & Echo Therapeutics (ECTE)
www.americanbankingnews.com - December 2 at 1:06 PM
Analyzing Innovus Pharmaceuticals (INNV) and Echo Therapeutics (ECTE)Analyzing Innovus Pharmaceuticals (INNV) and Echo Therapeutics (ECTE)
www.americanbankingnews.com - December 2 at 5:36 AM
Head to Head Contrast: Echo Therapeutics (ECTE) versus Innovus Pharmaceuticals (INNV)Head to Head Contrast: Echo Therapeutics (ECTE) versus Innovus Pharmaceuticals (INNV)
www.americanbankingnews.com - December 1 at 11:38 AM
Critical Analysis: Innovus Pharmaceuticals (INNV) versus Echo Therapeutics (ECTE)Critical Analysis: Innovus Pharmaceuticals (INNV) versus Echo Therapeutics (ECTE)
www.americanbankingnews.com - November 30 at 5:28 PM
Head-To-Head Comparison: Echo Therapeutics (ECTE) and Innovus Pharmaceuticals (INNV)Head-To-Head Comparison: Echo Therapeutics (ECTE) and Innovus Pharmaceuticals (INNV)
www.americanbankingnews.com - November 29 at 7:56 PM
Echo Therapeutics (ECTE) & Tonix Pharmaceuticals (TNXP) Head-To-Head AnalysisEcho Therapeutics (ECTE) & Tonix Pharmaceuticals (TNXP) Head-To-Head Analysis
www.americanbankingnews.com - November 27 at 5:28 AM
Comparing Innovus Pharmaceuticals (INNV) & Echo Therapeutics (ECTE)Comparing Innovus Pharmaceuticals (INNV) & Echo Therapeutics (ECTE)
www.americanbankingnews.com - November 24 at 11:16 PM
Comparing Tonix Pharmaceuticals Holding Corp. (TNXP) and Echo Therapeutics (ECTE)Comparing Tonix Pharmaceuticals Holding Corp. (TNXP) and Echo Therapeutics (ECTE)
www.americanbankingnews.com - November 23 at 5:24 AM
Reviewing Echo Therapeutics (ECTE) and Innovus Pharmaceuticals (INNV)Reviewing Echo Therapeutics (ECTE) and Innovus Pharmaceuticals (INNV)
www.americanbankingnews.com - November 21 at 9:55 AM
Financial Review: Tonix Pharmaceuticals Holding Corp. (TNXP) vs. Echo Therapeutics (ECTE)Financial Review: Tonix Pharmaceuticals Holding Corp. (TNXP) vs. Echo Therapeutics (ECTE)
www.americanbankingnews.com - November 20 at 7:52 PM
Echo Therapeutics (ECTE) vs. Innovus Pharmaceuticals (INNV) Head to Head ContrastEcho Therapeutics (ECTE) vs. Innovus Pharmaceuticals (INNV) Head to Head Contrast
www.americanbankingnews.com - November 20 at 11:50 AM
Contrasting Echo Therapeutics (ECTE) & Tonix Pharmaceuticals Holding Corp. (TNXP)Contrasting Echo Therapeutics (ECTE) & Tonix Pharmaceuticals Holding Corp. (TNXP)
www.americanbankingnews.com - November 20 at 7:54 AM
Financial Contrast: Echo Therapeutics (ECTE) vs. Tonix Pharmaceuticals Holding Corp. (TNXP)Financial Contrast: Echo Therapeutics (ECTE) vs. Tonix Pharmaceuticals Holding Corp. (TNXP)
www.americanbankingnews.com - November 19 at 7:12 AM
Echo Therapeutics (ECTE) and Innovus Pharmaceuticals (INNV) Head to Head ContrastEcho Therapeutics (ECTE) and Innovus Pharmaceuticals (INNV) Head to Head Contrast
www.americanbankingnews.com - November 18 at 5:20 PM
Financial Review: Tonix Pharmaceuticals Holding Corp. (TNXP) versus Echo Therapeutics (ECTE)Financial Review: Tonix Pharmaceuticals Holding Corp. (TNXP) versus Echo Therapeutics (ECTE)
www.americanbankingnews.com - November 16 at 3:36 PM
Echo Therapeutics (ECTE) vs. Innovus Pharmaceuticals (INNV) Head to Head ReviewEcho Therapeutics (ECTE) vs. Innovus Pharmaceuticals (INNV) Head to Head Review
www.americanbankingnews.com - November 16 at 5:20 AM
Tonix Pharmaceuticals Holding Corp. (TNXP) versus Echo Therapeutics (ECTE) Head-To-Head ComparisonTonix Pharmaceuticals Holding Corp. (TNXP) versus Echo Therapeutics (ECTE) Head-To-Head Comparison
www.americanbankingnews.com - November 15 at 10:10 AM

SEC Filings

Echo Therapeutics (OTCMKTS:ECTE) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Echo Therapeutics (OTCMKTS:ECTE) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Echo Therapeutics (OTCMKTS ECTE) Stock Chart for Friday, December, 15, 2017

Loading chart…

This page was last updated on 12/15/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.